Orthopedic Imaging Equipment Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Orthopedic Imaging Equipment Market Trends and Insights

Rising Prevalence of Musculoskeletal Disorders and Orthopedic Procedures

Musculoskeletal disorders were the largest contributor to years lived with disability worldwide and represented 17% of all years lived with disability. A 2025 systematic analysis using Global Burden of Disease 2021 data reported 1.69 billion musculoskeletal disorder cases globally in 2021, which was 95% higher than in 1990. The same body of evidence showed that disability-adjusted life years associated with these disorders rose 88% during that period. Osteoarthritis is expected to become the leading contributor to the musculoskeletal disease burden by 2050, especially among women. The orthopedic imaging equipment market therefore has demand across diagnosis, treatment planning, guided interventions, and follow-up care. More than half of people with symptomatic knee osteoarthritis are younger than 65 years old, extending imaging use beyond older adult care pathways. 

Aging Population and Higher Joint-Replacement Demand

Joint arthroplasty requires imaging before surgery, during planning, and after the procedure, which links procedure volumes to repeated equipment use. U.S. primary total knee arthroplasty volume rose from 603,704 procedures in 2013 to 1,013,533 procedures in 2022. The supplied research projects primary total knee arthroplasty volume at 2,793,919 procedures by 2040, with 5.9% annual growth, while total hip arthroplasty is projected to grow 7.6% annually through 2040. Hip and knee replacement volumes returned to, and exceeded, pre-pandemic levels across OECD countries in 2025. Germany, Switzerland, Poland, and Australia recorded leading increases in replacement volumes in the supplied research. The orthopedic imaging equipment market benefits when implant positioning, periprosthetic fracture assessment, and loosening detection require post-surgical surveillance.

AI-Enabled, 3D, and Low-Dose Imaging Workflows

The supplied research estimated that 30% to 40% of new orthopedic imaging tenders in 2025 and 2026 included AI capability specifications. GE HealthCare received FDA 510(k) clearance in March 2026 for Photonova Spectra, a photon-counting CT system designed to process up to 50 times more data than conventional CT. The system supports material separation and high-definition musculoskeletal tissue characterization in the supplied research. Canon Medical launched Ultimion in April 2026 as Japan’s first domestically manufactured photon-counting CT, with musculoskeletal scan protocols. The FDA issued final guidance for AI-enabled device software functions in 2025, covering performance validation and post-market monitoring^[1]. The orthopedic imaging equipment market favors suppliers that build cleared AI functions into image acquisition and workflow systems, rather than relying only on later-stage image processing.

Shift Toward Outpatient and Ambulatory Orthopedic Care

The move of orthopedic procedures toward ambulatory surgical centers and free-standing imaging sites is changing the end-user base for equipment suppliers. Medicare-certified ambulatory surgical centers totaled 6,308 facilities in 2023 and grew 2.5%, according to the Medicare Payment Advisory Commission. New orthopedic centers increasingly combine advanced C-arms, MRI, and robotic technologies in one-visit care models. The supplied research cited an August 2026 opening by Mid-State Orthopaedic ASC in Alexandria, Louisiana, as an example of this configuration. Compact equipment has a stronger fit in locations with smaller footprints and procedure-led workflows. The orthopedic imaging equipment market therefore provides openings for suppliers with products and commercial models designed for outpatient orthopedic care.

High Capital, Installation, and Lifecycle-Service Costs

Advanced orthopedic imaging systems in the supplied research carried procurement prices from USD 1 million to more than USD 3 million per unit. Shielded-room construction and commissioning added to the expenditure for systems that required fixed installations. Lifecycle service contracts represented 20% to 30% of new-system contract value in the supplied research, creating multi-year commitments for buyers. Community hospitals, rural health centers, and newer ambulatory surgical centers faced the greatest capital barriers. This leaves well-capitalized urban hospital systems better positioned to acquire AI-enabled premium platforms. The orthopedic imaging equipment market has room for leasing, shared-service, and consumption-based commercial models where facilities cannot fund large upfront purchases.

Shortage of Radiologists, Radiographers, and Musculoskeletal Specialists

A continuing radiologist shortage limits imaging capacity even when patient demand rises. A 2025 study projected that the U.S. radiologist workforce could increase from 37,482 in 2023 to 47,119-52,591 by 2055 without a material expansion in residency positions^[2]. Another 2025 analysis reported a cumulative gap of 21,645 radiology jobs relative to graduating trainees between 2014 and 2023^[3]. The U.S. population aged 65 years and older grew 38.6% from 2010 to 2020, while annual diagnostic radiology residency matches remained near 1,000-1,100 in the supplied research. Musculoskeletal reading backlogs can delay diagnosis and extend the interval before surgery. The orthopedic imaging equipment market consequently faces lower near-term scan throughput, even as staffing constraints make AI-assisted interpretation more important.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Modality: X-Ray Anchors Volume, CT Drives the Upgrade Cycle

X-ray held 33.9% of revenue in 2025 because it remained central to trauma assessment, fracture screening, and weight-bearing joint alignment analysis. Digital radiography continued to replace computed radiography, particularly where facilities were upgrading established X-ray rooms. Konica Minolta, Agfa-Gevaert, and Allengers Medical Systems competed in Asia-Pacific and Latin America, where the supplied research indicated lower digital radiography penetration than in Western markets. FUJIFILM launched the CALNEO CROSS Slim surgical C-arm in Japan in September 2026. Its tube head was 55% narrower than its predecessor, while ultrasound-supported tendon assessment and guided injections, and mobile C-arms supported ambulatory surgical center workflows.

CT was the fastest-growing modality, with the orthopedic imaging equipment market size for CT projected to expand at a 7.5% CAGR from 2026 to 2031. Photon-counting architectures and deep-learning reconstruction supported the shift toward higher-value CT systems. GE HealthCare’s Photonova Spectra, cleared in March 2026, was designed for material separation and high-definition musculoskeletal characterization. Canon Medical introduced CLEAR Motion and PIQE 1024 Matrix deep-learning reconstruction in July 2026 for its CT portfolio. MRI remained important for soft tissue, cartilage, and ligament assessment, and premium CT and MRI platforms raised revenue per unit faster than entry-level X-ray systems.

By Indication: Trauma Anchors Volume, Arthritis Reshapes Revenue Mix

Acute trauma and fracture diagnosis accounted for 21.5% of the orthopedic imaging equipment market share in 2025 and remained the largest indication segment. Emergency departments require rapid imaging for road injuries, sports injuries, and fall-related fractures. This produced a broad and steady volume base across hospitals, trauma centers, and urgent care pathways. Conventional X-ray remained the usual first imaging step for many fracture assessments. CT and MRI added clinical value in complex fractures and soft-tissue injuries, supporting a continuing role for mobile and fixed systems in the orthopedic imaging equipment market.

Arthritis and degenerative joint disease were the fastest-growing indication segments, with a forecast CAGR of 8.2% from 2026 to 2031. Osteoarthritis affected an estimated 595 million people globally in 2022 and is projected to be a leading contributor to musculoskeletal disease burden by 2050. Serial imaging is required throughout disease management, including baseline assessment, treatment planning, and follow-up. This repeated use pattern differed from the single-event imaging demand often associated with trauma. Spinal injuries and disorders required advanced imaging and intraoperative guidance, while sports injuries, osteoporosis, bone disorders, and musculoskeletal cancer required modality-specific pathways.

By End User: Hospitals Lead, Diagnostic Imaging Centers, and ASCs Surge

Hospitals and trauma centers held 42.8% of revenue in 2025, making them the largest end-user group in the orthopedic imaging equipment market. Their position reflected their role in trauma CT, intraoperative fluoroscopy, and MRI for complex joint and spine procedures. Hospital systems also had the infrastructure required for shielded rooms and specialist staffing. Large facilities, therefore, absorbed the highest-cost imaging platforms. Their purchasing often covered multiple modalities and service contracts, supporting established vendors with broad imaging portfolios.

Diagnostic imaging centers recorded the highest end-user CAGR at 8.5% from 2026 to 2031. Payers were directing elective musculoskeletal imaging toward lower-cost free-standing facilities in the supplied research. Ambulatory surgical centers were also becoming more important equipment customers as orthopedic procedures moved away from hospitals. CurveBeam AI’s HiRise CBCT received FDA clearance, Health Canada approval, and a CE mark under the EU Medical Device Regulation in 2025. The system was designed for orthopedic specialty clinics, and suppliers were responding with compact variants, separate channels, and consumption-based pricing.

Geography Analysis

North America held 42.4% of the orthopedic imaging equipment market share in 2025. The region benefited from a large installed base, high joint procedure volumes, and early uptake of AI-augmented imaging. The United States remained a major setting for joint arthroplasty, spine surgery, and sports medicine imaging in the supplied research. Canada added demand through weight-bearing CBCT adoption in orthopedic specialty clinics, including CurveBeam AI’s Enhanced HiRise system, which received Health Canada clearance in July 2025. The FDA’s February 2026 cybersecurity guidance made device security an important procurement consideration for networked imaging systems. 

Europe was the second-largest regional market in the supplied research, with Germany anchoring an advanced orthopedic imaging infrastructure. Germany’s orthopedic and trauma surgery settings provided stable, high-volume applications for diagnostic imaging equipment. The United Kingdom, France, and Italy formed the main demand base, while Spain and Portugal showed faster ambulatory orthopedic expansion. Siemens Healthineers presented Vuze 2 trackerless spinal guidance software in September 2026 for the Cios Spin C-arm, and the software achieved 95% median navigated pedicle screw placement accuracy in the supplied research. EU Medical Device Regulation 2017/745 continued to affect market-entry timing for suppliers entering Europe.

Asia-Pacific was the fastest-growing region, with the orthopedic imaging equipment market size projected to advance at a 6.4% CAGR through 2031. China’s medical imaging equipment sales reached CNY 75 billion, equivalent to USD 10.4 billion, in 2025 in the supplied research. The draft also expected 2,520 orthopedic CBCT units to ship in China during 2025. United Imaging Healthcare, Mindray, and Neusoft Medical competed through pricing and service responsiveness. Japan’s physician overtime rules increased interest in AI-enabled tools, while India, the Middle East, Africa, Brazil, and Argentina provided equipment-upgrade opportunities for the orthopedic imaging equipment market. These regional differences reflected varied care delivery settings, installed capacity, and local supplier presence in the supplied research.